RHÖN-KLINIKUM AG Reports Stable Q1 2026 Performance Amid Healthcare Reform Changes
RHÖN-KLINIKUM AG began the 2026 financial year with stable operational and financial performance as the healthcare provider continued expanding both inpatient and outpatient care structures across its hospital network. The company reported higher revenue, improved earnings, and increased patient volumes during the first quarter while continuing to prepare for significant regulatory and structural reforms affecting Germany’s healthcare sector.
Group revenue for the first quarter of 2026 reached EUR 436.1 million, slightly above the EUR 414.7 million recorded during the same period in 2025. Earnings before interest, taxes, depreciation, and amortization (EBITDA) improved significantly to EUR 30.2 million, compared with EUR 22.6 million a year earlier.
Net profit for the quarter rose to EUR 13.1 million from EUR 7.3 million in the prior-year period, reflecting stronger operational efficiency and increasing patient demand across the company’s healthcare facilities.
During the first three months of the year, RHÖN-KLINIKUM AG treated a total of 258,027 inpatient and outpatient cases, representing a 7.4% increase compared with 240,137 patients treated during the first quarter of 2025. The company said the increase highlights continued demand for medical services across its clinics, medical centers, and specialized care facilities.
Expanding Care Structures Across Hospital Network
RHÖN-KLINIKUM AG stated that its hospital sites continue to develop dynamically as the group focuses on strengthening both outpatient and inpatient care models. The company plans to make substantial investments throughout 2026 in modern medical technology and infrastructure upgrades at all hospital locations.
Management indicated that the investments are intended to improve patient care quality, expand therapeutic capabilities, and strengthen the group’s long-term competitiveness within Germany’s rapidly evolving healthcare landscape.
In addition to technology investments, RHÖN-KLINIKUM AG plans to continue broadening medical and therapeutic services across the organization. The company said these initiatives are aligned with its strategy of integrating healthcare services more closely across inpatient hospitals, outpatient clinics, and specialized treatment centers.
Strategic Acquisition Supports Campus Expansion
A major operational development during the quarter was the integration of the operating business of Ortho Centrum Saale MVZ GmbH into the RHÖN-KLINIKUM AG group structure.
Beginning in the first quarter of 2026, the results of the acquisition were consolidated into the group’s financial statements. The acquisition includes six publicly funded medical practices specializing in orthopedics, trauma surgery, general surgery, sports medicine, sports traumatology, and neurosurgery.
The company said the transaction is designed to strengthen the RHÖN campus concept in Bad Neustadt while creating additional growth opportunities in both clinical and outpatient healthcare services throughout the Rhön-Grabfeld region.
Management believes the acquisition will improve care coordination between outpatient specialists and hospital-based treatment facilities while also enhancing patient access to integrated medical services.
The addition of the orthopedic and surgical practices is expected to support long-term patient growth and improve the company’s position in highly specialized medical disciplines that continue to experience rising demand in Germany’s healthcare system.
Outlook for Fiscal Year 2026
Looking ahead, RHÖN-KLINIKUM AG reaffirmed its expectations for continued stable business development during fiscal year 2026 despite growing uncertainty related to healthcare reform implementation and broader economic pressures.
The company expects full-year revenue to reach approximately EUR 1.7 billion, with a possible variation of plus or minus 5%. EBITDA for the year is projected to range between EUR 110 million and EUR 125 million.
In addition to traditional financial measures, RHÖN-KLINIKUM AG also monitors non-financial performance indicators such as patient case numbers and operational valuation ratios as part of its management strategy. The company expects moderate growth in these indicators compared with the previous year.
Management noted that the overall business environment remains heavily influenced by ongoing legislative and regulatory developments within Germany’s healthcare system. The company emphasized that the current fiscal year will be significantly shaped by the implementation of healthcare reforms and the uncertainties surrounding future policy decisions.
Healthcare Reform Creates Uncertainty
RHÖN-KLINIKUM AG highlighted several legislative developments that are expected to impact hospitals and healthcare providers throughout Germany during 2026.
Among the most significant changes is the Hospital Reform Adjustment Act (KHAG), which officially came into force on April 15, 2026. According to the company, the legislation aims to improve efficiency and quality standards across the healthcare system but also places additional financial pressure on hospitals in the near term.
The company also referenced the ongoing effects of the Statutory Health Insurance Financial Stabilization Act (GKV-FinStG), which continues to affect reimbursement structures and operating economics for healthcare providers.
Management stated that while the reforms are intended to modernize healthcare delivery and improve long-term sustainability, they also create considerable uncertainty for hospitals attempting to maintain stable financial performance while continuing to deliver high-quality patient care.
RHÖN-KLINIKUM AG cautioned that the full financial and operational effects of the reforms cannot currently be predicted with certainty due to the complexity of the legislative changes and the potential for further adjustments by policymakers.
Economic Pressures Continue to Impact Healthcare Sector
In addition to regulatory challenges, RHÖN-KLINIKUM AG noted that hospitals continue to face broader economic pressures associated with global instability and inflationary trends.
The company cited rising prices, supply chain bottlenecks, and volatile market conditions as ongoing challenges affecting operational costs and investment planning throughout the healthcare sector.
These economic burdens have increased pressure on hospitals already adapting to changing reimbursement models and healthcare reform initiatives. Management stressed that maintaining economically sustainable operations while preserving high-quality patient care remains a key priority for healthcare providers across Germany.
The company said future adjustments to healthcare reforms, along with supportive policy measures, will likely be necessary to ensure hospitals can continue operating effectively and meeting patient needs over the long term.
Leadership Highlights Need for Stable Framework Conditions
RHÖN-KLINIKUM AG leadership emphasized the importance of stable political and economic conditions for the future sustainability of hospitals and healthcare services.
Dr. Stefan Stranz, Chief Executive Officer of RHÖN-KLINIKUM AG, said reliable medical care depends on financially stable hospitals, particularly during periods of major healthcare reform.
“Reliable medical care requires economically stable hospitals,” Stranz stated. “Especially in light of the current reforms, it will be crucial whether financing and framework conditions continue to enable hospitals to sustainably fulfill their care mandate.”
Dr. Gunther K. Weiß, also Chief Executive Officer of RHÖN-KLINIKUM AG, highlighted the company’s operational flexibility and collaboration within the ASKLEPIOS Group as important advantages during uncertain market conditions.
“Our business processes are efficient and flexible at the same time,” Weiß said. “A significant factor in this is the close and trusting collaboration within the ASKLEPIOS Group.”
He added that ongoing regulatory interventions and healthcare reforms continue to create substantial uncertainty for the industry.
“To ensure high-quality and reliable patient care in the long term, hospitals need stable economic and political framework conditions,” Weiß said.
Focus on Long-Term Growth and Integrated Care
Despite regulatory and economic uncertainty, RHÖN-KLINIKUM AG continues focusing on long-term expansion and modernization strategies designed to strengthen its integrated healthcare network.
The company’s investment initiatives, outpatient expansion strategy, and specialized care development efforts are intended to position the group for sustainable growth as Germany’s healthcare system evolves.
By integrating outpatient medical centers more closely with hospital operations, RHÖN-KLINIKUM AG aims to improve efficiency, strengthen patient pathways, and enhance healthcare accessibility across the regions it serves.
Management believes the company’s combination of advanced medical technology, specialized expertise, and integrated care models will remain important competitive advantages in the years ahead.
The company’s full quarterly report for the first quarter of 2026 has been published online through its investor relations platform.
About
For the coming fiscal year, we anticipate revenue of EUR 1.7 billion, with a range of +/-5% above or below this figure. We expect earnings before interest, taxes, depreciation, and amortization (EBITDA) to be between EUR 110 million and EUR 125 million. In addition to financial metrics, we consider non-financial performance indicators such as the number of cases and valuation ratios when managing the company, and we expect a moderate increase in these compared to the previous year.
The current fiscal year will be significantly shaped by the legislative processes and the considerable uncertainties associated with them. In particular, the Hospital Reform Adjustment Act (KHAG), which came into force on April 15, 2026, and the repercussions of the Statutory Health Insurance Financial Stabilization Act (GKV-FinStG), while aiming to further strengthen quality and efficiency in the healthcare system, simultaneously increase the short-term financial pressure on hospitals.
The company’s forecast is therefore subject to considerable uncertainty. The overall impact of ongoing regulatory interventions, the implementation of hospital reform, and potential further legislative adjustments cannot currently be reliably predicted. Added to this are persistent global crises and economic burdens, which manifest themselves, among other things, in price increases, supply bottlenecks, and volatile market conditions.
Against this background, it will be crucial whether further adjustments to the reforms and supporting measures are implemented to enable hospitals to continue providing economically viable and high-quality patient care in the future.
